These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 520683)

  • 21. Susceptibility to rubella and borderline immunity.
    Fogel A; Barnea B; Gerichter CB
    Isr J Med Sci; 1983 Oct; 19(10):934-5. PubMed ID: 6363349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Results of a trial of anti-rubella vaccination with vaccine made up of the "Cendehill-51" live and attenuated virus strain].
    Portolani M; Rondinini B; Brighi W; Maccolini E
    Minerva Med; 1970 Apr; 61(30 Suppl):1590-4. PubMed ID: 5439724
    [No Abstract]   [Full Text] [Related]  

  • 23. [Rubella screening and directed vaccination of 14-year-old girls with live rubella vaccine RA 27/3 in the Liberec district].
    Strauss J; Zikmundová V; Stovicek Z; Zikmund V; Téminová V; Langhammer O; Kokesová O
    Cesk Epidemiol Mikrobiol Imunol; 1982 Sep; 31(5):266-76. PubMed ID: 6215992
    [No Abstract]   [Full Text] [Related]  

  • 24. Rubella susceptibility in sixth graders: effectiveness of current immunization practice.
    Lawless MR; Abramson JS; Harlan JE; Kelsey DS
    Pediatrics; 1980 Jun; 65(6):1086-9. PubMed ID: 7375231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of immunoglobulin M-antibodies after rubella immunization with RA27/3 attenuated live vaccine in teen-agers: remaining problems.
    Braito A; Fanti O; Rossolini GM; Cellesi C
    Boll Ist Sieroter Milan; 1991-1992; 70(1-2):443-8. PubMed ID: 1670047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination by non-parenteral routes: characteristics of immune response.
    Ogra PL; Chiba Y; Beutner KR; Morag A
    Dev Biol Stand; 1976; 33():19-26. PubMed ID: 782968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Duration of immunity after rubella vaccination: a long-term study in Switzerland.
    Just M; Just V; Berger R; Burkhardt F; Schilt U
    Rev Infect Dis; 1985; 7 Suppl 1():S91-4. PubMed ID: 4001742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immune status of a school-population sample 5 years after antirubella vaccination].
    Quaglio P; Dattoli A; Mantovani G
    G Batteriol Virol Immunol; 1982; 75(7-12):233-8. PubMed ID: 7188256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positive rates for rubella antibody in pregnant women and benefit of post-partum vaccination in a Japanese perinatal center.
    Okuda M; Yamanaka M; Takahashi T; Ishikawa H; Endoh M; Hirahara F
    J Obstet Gynaecol Res; 2008 Apr; 34(2):168-73. PubMed ID: 18412777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of cell-mediated immunity to rubella virus 5 years after rubella vaccination.
    Rossier E; Phipps PH; Polley JR; Webb T
    Can Med Assoc J; 1977 Mar; 116(5):481-4. PubMed ID: 837312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rubella: the U. S. experience.
    Hinman AR; Preblud SR; Brandling-Bennett AD
    Dev Biol Stand; 1979; 43():315-26. PubMed ID: 520678
    [No Abstract]   [Full Text] [Related]  

  • 32. [Results of rubella prevention in Austria (1988 status)].
    Hofmann H; Kunz C
    Wien Med Wochenschr; 1989 Jul; 139(14):330-3. PubMed ID: 2773490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Live attenuated rubella vaccine (Cendehill strain) in school children.
    Hutchison PA; Izumi T; Davidson WG; Grocott HC; Martin HM
    Can Med Assoc J; 1970 Oct; 103(7):728-31. PubMed ID: 5506107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guide to the management of rubella problems.
    Middleton PJ; Larke RP; Lessard P; Doran TA
    Can Med Assoc J; 1977 Mar; 116(5):484-8. PubMed ID: 837313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study on rubella immunization in Thailand. 2. Clinical observations on vaccinated children with Cendehill strain.
    Thongcharoen P; Bukkavesa S; Habanananda S; Jaiwatana S; Chearskul S; Oonsombat P; Charoenrath M; Wasi C; Panpatana P; Sarasombath S
    J Med Assoc Thai; 1974 Sep; 57(9):439-41. PubMed ID: 4425433
    [No Abstract]   [Full Text] [Related]  

  • 36. Trials with a live attenuated rubella virus vaccine, Cendehill strain.
    Grant L; Belle EA; Provan G; King SD; Sigel MM
    J Hyg (Lond); 1970 Sep; 68(3):505-10. PubMed ID: 5272349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rubella-vaccinated students. Follow-up in a public school system.
    Schiff GM; Rauh JL; Young B; Trimble S; Rotte T; Schiff BE
    JAMA; 1978 Dec; 240(24):2635-7. PubMed ID: 712979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Rubella epidemiology in rural Upper Volta].
    Monjour L; Druilhe P; Huraux JM; Palminteri R; Froment A; Kyelem JM; Alfred C; Laplace JL; Gentilini M
    Acta Trop; 1982 Sep; 39(3):247-52. PubMed ID: 6128893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Rubella. epidemiological studies and experiences with an attenuated vaccine ("Cendehill strain")].
    Majer R
    Helv Paediatr Acta; 1967 Dec; 22(6):579-90. PubMed ID: 4874394
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunity to intranasal challenge with Rubella virus two years after vaccination: comparison of three vaccines.
    Grillner L
    J Infect Dis; 1976 Jun; 133(6):637-41. PubMed ID: 932491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.